跳到主要內容

Maetzold Derek J 的 Form 4 申報

Castle Biosciences Inc(CSTL),2021/10/8 申報

申報編號
0001447362-21-000237
申報時間
2021/10/8
交易日
2021/10/6
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $15.9 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Maetzold Derek JCIK 0001239501董事、高階主管(總裁、執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2021/10/6Common StockS賣出處分−511$63.49F2−$32,443.39131,783間接
2021/10/6Common StockS賣出處分−322$64.14F4−$20,653.08131,461間接
2021/10/6Common StockS賣出處分−512$63.49F2−$32,506.88154,622間接
2021/10/6Common StockS賣出處分−322$64.14F4−$20,653.08154,300間接
2021/10/6Common StockS賣出處分−511$63.49F2−$32,443.39142,021間接
2021/10/6Common StockS賣出處分−322$64.14F4−$20,653.08141,699間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $62.79 to $63.77, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

F4

This transaction was executed in multiple trades at prices ranging from $63.83 to $64.45, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)